Literature DB >> 13126200

Hemophilic syndromes and hemophilia.

L M TOCANTINS.   

Abstract

Entities:  

Keywords:  HEMOPHILIA

Mesh:

Year:  1954        PMID: 13126200

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

1.  [The problem of existence of several blood coagulation factors of the blood thrombokinase formation].

Authors:  R MARX
Journal:  Klin Wochenschr       Date:  1955-02-01

2.  Application of continuous flow electrophoresis to the study of the blood coagulation proteins. II. The hemophilias (A and B).

Authors:  J H LEWIS; W R MERCHANT
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

3.  [Clarification of concepts in the problem of hemophilia].

Authors:  K LENGGENHAGER; L BUCHLER
Journal:  Klin Wochenschr       Date:  1957-05-15

4.  Antithromboplastin: the degeneration of intrinsic thromboplastin in normal serum.

Authors:  C G BERRY
Journal:  J Clin Pathol       Date:  1958-01       Impact factor: 3.411

5.  [Reciprocal effects between the promoting and inhibiting substances of the blood coagulation].

Authors:  E HECHT
Journal:  Experientia       Date:  1954-10-15

6.  The effect of glass upon the activity of the various plasma clotting factors.

Authors:  S I RAPAPORT; K AAS; P A OWREN
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

7.  [Blood platelets and coagulationactive plasma proteins. A short summary of their function and pathology].

Authors:  E MAMMEN; R GROSS
Journal:  Blut       Date:  1962-05

8.  [Increase of factor VIII-(antihemophilic globulin)-activity in plasma of hemophiliacs following addition of synthetic fibrinolytic compounds].

Authors:  E von Kaulla; K N von Kaulla
Journal:  Klin Wochenschr       Date:  1973-07-15

9.  [Hemophilia, deficiency condition or excess of antibodies?].

Authors:  E Hecht
Journal:  Klin Wochenschr       Date:  1966-07-15

10.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.